NBIX · Neurocrine Biosciences Inc · Documents
$145.53
-0.47 (-0.32%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$14.84B
Shares
101.65M
Volume · Oct 28
877.23K
Avg daily vol (3M)
1.32M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-05-23 | 2024-05-22 | |
| 8-K | — | 2024-05-01 | — | |
| 10-Q | — | 2024-05-01 | 2024-03-31 | |
| DEF 14A | — | 2024-04-10 | 2024-05-22 | |
| ARS | — | 2024-04-10 | 2023-12-31 | |
| DEFA14A | — | 2024-04-10 | — | |
| 10-K | — | 2024-02-09 | 2023-12-31 | |
| 8-K | — | 2024-02-07 | — | |
| 8-K | — | 2023-11-13 | 2023-11-10 | |
| 8-K | — | 2023-11-09 | — | |
| 8-K | — | 2023-10-31 | — | |
| 10-Q | — | 2023-10-31 | 2023-09-30 | |
| 8-K | — | 2023-10-06 | 2023-10-05 | |
| 8-K | — | 2023-10-05 | — | |
| 8-K | — | 2023-09-12 | — | |
| 8-K | — | 2023-08-01 | — | |
| 10-Q | — | 2023-08-01 | 2023-06-30 | |
| 8-K | — | 2023-07-13 | 2023-07-10 | |
| 8-K | — | 2023-07-12 | 2023-07-11 | |
| 8-K | — | 2023-05-19 | 2023-05-17 | |
| 10-Q | — | 2023-05-03 | 2023-03-31 | |
| 8-K | — | 2023-05-03 | — | |
| DEFA14A | — | 2023-05-02 | — | |
| ARS | — | 2023-04-06 | 2022-12-31 | |
| DEF 14A | — | 2023-04-05 | — | |
| DEFA14A | — | 2023-04-05 | — | |
| 8-K | — | 2023-03-29 | 2023-03-28 | |
| 8-K | — | 2023-02-24 | 2023-02-21 | |
| 8-K | — | 2023-02-10 | — | |
| 10-K | — | 2023-02-09 | 2022-12-31 | |
| 8-K | — | 2023-02-06 | — | |
| 8-K | — | 2023-01-09 | 2023-01-08 | |
| 10-Q | — | 2022-11-01 | 2022-09-30 | |
| 8-K | — | 2022-11-01 | — | |
| 8-K | — | 2022-08-30 | — | |
| 8-K | — | 2022-08-04 | — | |
| 10-Q | — | 2022-08-04 | 2022-06-30 | |
| 8-K | — | 2022-06-01 | 2022-05-31 | |
| 8-K | — | 2022-05-25 | 2022-05-24 | |
| 8-K | — | 2022-05-23 | 2022-05-18 | |
| 10-Q | — | 2022-05-04 | 2022-03-31 | |
| 8-K | — | 2022-05-04 | — | |
| DEFA14A | — | 2022-04-07 | — | |
| DEF 14A | — | 2022-04-07 | 2022-05-18 | |
| 8-K | — | 2022-02-11 | — | |
| 10-K | — | 2022-02-11 | 2021-12-31 | |
| 8-K | — | 2022-01-06 | — | |
| 8-K | — | 2021-12-23 | 2021-12-22 | |
| 8-K | — | 2021-11-22 | — | |
| 8-K | — | 2021-11-01 | — |
Showing 51–100 of 134 filings
Key facts
CIK
914475
CUSIP
64125C109
13F (30d)
195 filings
184 filers
Visit website
Investor relations